InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the detailed record of transactions filed by Petree Daniel H, Director. Director active across 1 company, notably Sutro Biopharma, INC.. Cumulatively, 2 reports have been published. Activity tracked since 8 February 2022. The latest transaction was filed on 8 February 2022 (Levée d'options). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations2 total
4,545 shares@ US$4.360.0027% mcap50.0% of flowCommon StockSEC:0001209191-22-008198:0
4,545 shares@ US$4.360.0027% mcap100.0% of flowCommon StockSEC:0001209191-22-008198
2 of 2 declarations
About Petree Daniel H
Daniel H. Petree is a Director at SUTRO BIOPHARMA, INC., a biotechnology company. As a director, he contributes to the governance of the company and to strategic decision-making. His experience in the biotechnology field is an asset for SUTRO.
